Tag Archives: Mark Collen

Markets in everything, Medicare drug testing edition

Mark Collen has an important discussion of the profit motive that drives drug testing in America’s health system. Read the whole thing if you are interested, it is important:

Random drug testing of people being treated for chronic pain has become more common. Physicians may drug test patients on opioid therapy as a result of concerns over prosecution, drug misuse, addiction, and overdose. However, profit motive has remained unexplored. This article suggests profits also drive physician drug-testing behavior and evidence is offered, including an exploration of Medicare reimbursement incentives and kickbacks for drug testing.


Tagged ,